CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX) announced today that Curtis T. Keith, Ph.D., Senior Vice President, Research and a co-founder of the Company, is leaving the CombinatoRx management team to accept a position at Harvard University as Chief Scientific Officer for the Office of Technology Development Accelerator Fund. Dr. Keith will remain with CombinatoRx as a member of its scientific advisory board.
